Allergan
 
2Q Revenues: $1.5 billion (+5%)

2Q Earnings: $296.4 million (+19%)

YTD Revenues: $2.9 billion (+7%)

YTD Earnings: $526.7 million (+29%)

Comments: Specialty pharmaceutical sales were up 5% to $1.2 billion in the quarter. Botox sales were $461.2 million (+10%). Restasis sales were $196.0 million (+13%). Latisse sales were $26.0 million (+19%). Medical device sales were up 4% to $254.8 million.